Belgium vs Slovenia: Number of isolates tested for ceftriaxone
Belgium
159
in 2020
Slovenia
168
in 2020
Belgium rank
20th
Slovenia rank
19th
Number of isolates tested for ceftriaxone over time
- Belgium
- Slovenia
How they compare
Slovenia currently reports 168 against 159 in Belgium, a difference of 9.
That makes Slovenia's figure about 1.1 times Belgium's.
The two have swapped places 3 times across 10 shared years of data; in 2009 it was Belgium ahead.
Belgium ranks 20th and Slovenia ranks 19th of 52 countries.
Across the 3 decades both report, Belgium averaged higher in 2 and Slovenia in 1.
Head to head by decade
| Decade | Belgium | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 110 | 24 | 86 | Belgium |
| 2010s | 114.12 | 83.75 | 30.38 | Belgium |
| 2020s | 159 | 168 | 9 | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, Belgium or Slovenia?
- Slovenia, at 168 against 159 in Belgium as of 2020.
- What is the difference in number of isolates tested for ceftriaxone between Belgium and Slovenia?
- 9, with Slovenia ahead.
- How many years of comparable data are there for Belgium and Slovenia?
- 10 years are reported by both, from 2009 to 2020.
- How do Belgium and Slovenia rank globally for number of isolates tested for ceftriaxone?
- Belgium ranks 20th and Slovenia ranks 19th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.